These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6748319)

  • 1. [A case of fulminant hepatitis developing in a HBsAG carrier after chemotherapy of malignant lymphoma].
    Hanta T; Okita K; Matsuda S; Konishi T; Yasunaga M; Kado Y; Nawata H; Ogino M; Shingai Y; Fukumoto Y
    Nihon Shokakibyo Gakkai Zasshi; 1984 Apr; 81(4):1089-93. PubMed ID: 6748319
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulminant delta hepatitis in chronic asymptomatic HBsAg carriers.
    Tassopoulos N; Roumeliotou-Karayannis A; Nakopoulou L; Calafatas P; Papaevangelou G
    JAMA; 1985 Apr; 253(16):2362-3. PubMed ID: 3981762
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between carriage of HBeAg and HBsAg.
    Hyland CA; Shanley BC
    Lancet; 1983 Nov; 2(8359):1140-1. PubMed ID: 6138669
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal hepatitis B in infant born to a HBsAg carrier with HBeAb.
    Ewing CI; Davidson DC
    Arch Dis Child; 1985 Mar; 60(3):265-7. PubMed ID: 3985661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The incidence of hepatitis B and HBsAg carrier state in families caused by (nonparenteral) contact].
    Horejsí J; Cerhová M; Jezková Z; Májský A; Mimra J; Novák J; Svorcová V
    Vnitr Lek; 1980 Apr; 26(4):234-41. PubMed ID: 7385610
    [No Abstract]   [Full Text] [Related]  

  • 6. [The quantitative determination of HBSAG--a valuable aid in evaluating the infectiousness of hepatitis B virus carriers].
    Löschner J; Fengler JD; Baumgarten R
    Z Arztl Fortbild (Jena); 1981 Nov; 75(22):1084-5. PubMed ID: 7340196
    [No Abstract]   [Full Text] [Related]  

  • 7. [An HBsAg carrier who became carrier through exchange transfusion and developed liver cirrhosis despite the disappearance of HBsAg].
    Ishihara K; Hayashi J; Kajiyama W; Ishibashi H; Kashiwagi S
    Kansenshogaku Zasshi; 1988 Jun; 62(6):608-12. PubMed ID: 3138332
    [No Abstract]   [Full Text] [Related]  

  • 8. [HLA antigens in blood donors, asymptomatic chronic carriers of the viral hepatitis type B surface antigen (HBsAg)].
    Morales VH; Barbetti A; Basualdo JA; Jmelnitzky A; Landoni N; Ponce de León H; Chopita N; de Torres RA
    Medicina (B Aires); 1983; 43(2):175-80. PubMed ID: 6664285
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B surface antigen (HbsAg): (a survey of hospital staff in Zambia).
    Bhagwat GP; Parmar S
    Med J Zambia; 1983 Oct; 17(4):106-8. PubMed ID: 6680555
    [No Abstract]   [Full Text] [Related]  

  • 10. [A follow-up study on HBsAg carriers and factors affecting negative-conversion].
    Hong DQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1984 Jan; 18(1):32-4. PubMed ID: 6468123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Positive HBsAg in 3 sisters carrying identical HLA].
    Marzo L; Buñuel C; Aztarain E; Raichs A
    Sangre (Barc); 1984; 29(1):93-4. PubMed ID: 6719323
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of HBsAg in circulating immune complexes in asymptomatic carriers & various hepatic disorders due to hepatitis B virus.
    Gupta H; Tandon BN
    Indian J Med Res; 1988 Aug; 88():111-7. PubMed ID: 3198168
    [No Abstract]   [Full Text] [Related]  

  • 13. [Outpatient follow-up of HBsAg-positive blood donors].
    Glasa J; Holomán J; Stancek D; Kupcová V; Jambor P; Páleníková O; Brixová E
    Bratisl Lek Listy; 1988 Mar; 89(3):220-5. PubMed ID: 3390730
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical evaluation of ultrafiltrate in dialysis-dependent HBsAG-positive patients.
    Andrew R; Hariharan S; Saha V; John JT; Kirubakaran MG; Shastry JC
    Nephron; 1988; 49(1):88. PubMed ID: 3380225
    [No Abstract]   [Full Text] [Related]  

  • 15. [Importance of the immune system in the symptom-free HBsAg carrier state].
    Mansurov KhKh; Asfandiiarova NS
    Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes of HBeAg/anti-HBeAb system in chronic type B hepatitis, especially acute hepatitis from HBsAg carriers and persistent hepatitis].
    Kasajima M
    Nihon Shokakibyo Gakkai Zasshi; 1984 Jul; 81(7):1574-81. PubMed ID: 6492455
    [No Abstract]   [Full Text] [Related]  

  • 17. [106 cases of HBsAg carriers and factors influencing the prognosis: a follow-up study of 7-12 years].
    Hong DQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Aug; 6(4):223-6. PubMed ID: 4092225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term observation of HBsAg positive patients and carriers (author's transl)].
    Wu BP
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jul; 15(4):245-7. PubMed ID: 7333195
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of anti-delta antibodies in chronic HBsAg carriers].
    Stránský J; Zichová M; Vodák M
    Cas Lek Cesk; 1987 Dec; 126(51):1600-3. PubMed ID: 3442788
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-lasting abatement of HBsAg synthesis induced by acute delta infection.
    Frommel D; Allain JP; Courouce AM; Derose S; Trepo D; Crivelli O; Rizzetto M
    Lancet; 1983 Mar; 1(8325):656-7. PubMed ID: 6131340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.